Structure, Mechanism and Interactions of Type IA Topoisomerases
IA型拓扑异构酶的结构、机制和相互作用
基本信息
- 批准号:10389425
- 负责人:
- 金额:$ 6.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:ComplexCrystallizationDNAEquipmentEscherichia coliFundingGrantHumanLigandsMolecular ConformationMycobacterium tuberculosisNational Institute of General Medical SciencesProteinsRNARecombinantsRequest for ApplicationsResearchStructureSystemTimeTopoisomeraseTopoisomerase IIIType I DNA TopoisomerasesUnited States National Institutes of HealthX-Ray Crystallographybiophysical analysisfast protein liquid chromatographyinhibitor/antagonistmilligrammutantprotein protein interactionprotein purificationrepairedsingle molecule
项目摘要
Project Summary PI: Yuk-Ching Tse-Dinh
This equipment supplement application requests funds to purchase an AKTA FPLC protein
purification system for the large scale purification of recombinant topoisomerase proteins that
are needed for obtaining new structures of topoisomerases by X-ray crystallography, and
biophysical studies to elucidate topoisomerase complex conformations, protein-protein
interactions and ligand interaction dynamics under the aims of the PI’s NIGMS active grants
R01-GM054226 and R35-GM139817. The AKTA FPLC protein purification system currently
available in the PI’s lab requires frequent repairs and needs to be replaced to avoid extensive
down times. The replacement of the AKTA FPLC purification system would allow us to produce
quickly and efficiently without bottlenecks milligram quantities of wild-type and mutant forms of
Escherichia coli and Mycobacterium tuberculosis topoisomerase I, E. coli topoisomerase III, and
human topoisomerase IIIB for structural and biophysical studies of their action on both DNA and
RNA substrates, as well as inhibitors. The proteins need to be produced in high purity for
studies in our lab at FIU, and are also needed by our collaborators at Argonne National Lab and
NIH for crystallization screens and single-molecule studies.
PI: Yuk-Ching Tse-Dinh
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuk-Ching Tse-Dinh其他文献
Yuk-Ching Tse-Dinh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuk-Ching Tse-Dinh', 18)}}的其他基金
Structure, Mechanism and Interactions of Type IA Topoisomerases
IA型拓扑异构酶的结构、机制和相互作用
- 批准号:
10093404 - 财政年份:2021
- 资助金额:
$ 6.03万 - 项目类别:
Structure, Mechanism and Interactions of Type IA Topoisomerases
IA型拓扑异构酶的结构、机制和相互作用
- 批准号:
10569676 - 财政年份:2021
- 资助金额:
$ 6.03万 - 项目类别:
HTS assay development targeting Yersinia pestis topoisomerase I
针对鼠疫耶尔森菌拓扑异构酶 I 的 HTS 检测开发
- 批准号:
8234706 - 财政年份:2010
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing by topoisomerase I mediated DNA lesion
拓扑异构酶 I 介导的 DNA 损伤杀死细菌细胞
- 批准号:
8070106 - 财政年份:2010
- 资助金额:
$ 6.03万 - 项目类别:
HTS assay development targeting Yersinia pestis topoisomerase I
针对鼠疫耶尔森菌拓扑异构酶 I 的 HTS 检测开发
- 批准号:
7991064 - 财政年份:2010
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing by topoisomerase I mediated DNA lesion
拓扑异构酶 I 介导的 DNA 损伤杀死细菌细胞
- 批准号:
7756650 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing by topoisomerase I mediated DNA lesion
拓扑异构酶 I 介导的 DNA 损伤杀死细菌细胞
- 批准号:
8186092 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing by topoisomerase I mediated DNA lesion
拓扑异构酶 I 介导的 DNA 损伤杀死细菌细胞
- 批准号:
7169238 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing topoisomerase I--DNA lesion
细菌细胞杀伤拓扑异构酶I--DNA损伤
- 批准号:
7083065 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
Bacterial cell killing by topoisomerase I mediated DNA lesion
拓扑异构酶 I 介导的 DNA 损伤杀死细菌细胞
- 批准号:
7333269 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
相似海外基金
Dynamic Pathways to Crystallization of DNA-Coated Colloids
DNA 包被胶体结晶的动态途径
- 批准号:
2214590 - 财政年份:2022
- 资助金额:
$ 6.03万 - 项目类别:
Continuing Grant
Protein Crystallization Programmed with DNA
用 DNA 编程的蛋白质结晶
- 批准号:
2104353 - 财政年份:2021
- 资助金额:
$ 6.03万 - 项目类别:
Standard Grant
Phase transitions and crystallization of DNA-coated colloids
DNA 包被胶体的相变和结晶
- 批准号:
1610788 - 财政年份:2016
- 资助金额:
$ 6.03万 - 项目类别:
Continuing Grant
CO CRYSTALLIZATION OF MULTIPROTEIN-DNA COMPLEXES FOR STRUCTURAL ANALYSIS:
用于结构分析的多蛋白-DNA 复合物共结晶:
- 批准号:
8363529 - 财政年份:2011
- 资助金额:
$ 6.03万 - 项目类别:
CO CRYSTALLIZATION OF MULTIPROTEIN-DNA COMPLEXES FOR STRUCTURAL ANALYSIS:
用于结构分析的多蛋白-DNA 复合物共结晶:
- 批准号:
7955580 - 财政年份:2009
- 资助金额:
$ 6.03万 - 项目类别:
2D MEMBRANE PROTEIN CRYSTALLIZATION USING DNA TEMPLATE
使用 DNA 模板进行 2D 膜蛋白结晶
- 批准号:
7721145 - 财政年份:2007
- 资助金额:
$ 6.03万 - 项目类别:
X-ray crystallographic analysis of DNA using temperature-control crystallization technique
使用温控结晶技术对 DNA 进行 X 射线晶体学分析
- 批准号:
18790030 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CO CRYSTALLIZATION OF MULTIPROTEIN-DNA COMPLEXES FOR STRUCTURAL ANALYSIS
用于结构分析的多蛋白-DNA 复合物共结晶
- 批准号:
7357740 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
2D MEMBRANE PROTEIN CRYSTALLIZATION USING DNA TEMPLATE
使用 DNA 模板进行 2D 膜蛋白结晶
- 批准号:
7598611 - 财政年份:2006
- 资助金额:
$ 6.03万 - 项目类别:
2D MEMBRANE PROTEIN CRYSTALLIZATION USING DNA TEMPLATE
使用 DNA 模板进行 2D 膜蛋白结晶
- 批准号:
7357803 - 财政年份:2005
- 资助金额:
$ 6.03万 - 项目类别: